Search Results

Researchers at the newly-formed Optimal Aging Institute at NYU Langone Health have been awarded $31 million by the National Institutes of Health for a diverse, ten university cohort to study how vascular risk factors contribute to dementia and other age-related disorders in those over the age of 85, building upon existing research.

Roughly 11 percent of people living in the United States have type 2 diabetes and nearly 40 percent of adults have prediabetes, according to the Centers for Disease Control and Prevention.

Following a national search, NYU Langone Health is pleased to announce that Mario E. Lacouture, MD, has been named the new Chief of the Dermatology Division, Department of Medicine, Long Island.

Royal Philips and NYU Langone Health announced an 8-year strategic partnership valued up to USD 115 million and aimed at enhancing patient care through further innovation.

NYU Langone Health and Brown University’s School of Public Health announced a grant award from the National Institute on Drug Abuse, part of the National Institutes of Health, to conduct research to measure the impact of some of the first publicly recognized overdose prevention centers in the United States, located in New York City and Providence, Rhode Island.

Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center at NYU Langone Health to validate its application for the early detection of pancreatic ductal adenocarcinoma.

Brooklyn Center, the 281-bed skilled nursing facility on Buffalo Avenue in the Crowne Heights section in Brooklyn, is welcoming Richard J. Batka, MD, NYU Langone’s Rusk Rehabilitation highly-esteemed physiatrist to their therapy team.

Medical iSight Corp (‘MiS’), developer of a next-generation 3D digital surgery platform, is pleased to announce a development partnership with NYU Langone Health’s Division of Neuroradiology.

NYU Langone Health and Deerfield Management Company, a healthcare investment firm, announced the launch of a research and development collaboration designed to accelerate the commercialization of biomedical discoveries.

Surgical teams at NYU Langone Health performed the world’s first genetically modified pig kidney transplants into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022.